<?xml version="1.0" encoding="utf-8"?>
<rss xmlns:content="http://purl.org/rss/1.0/modules/content/" version="2.0">
  <channel>
    <title><![CDATA[Drug Delivery Technology Industry: Market Research Reports, Statistics and Analysis]]></title>
    <link>http://www.reportlinker.com/ci02258/Drug-Delivery-Technology.html</link>
    <description><![CDATA[Reportlinker.com Lastest Drug Delivery Technology Industry: Market Research Reports, Statistics and Analysis]]></description>
    <pubDate>Fri, 24 May 2013 07:34:40 +0000</pubDate>
    <webMaster>helpdesk@reportlinker.com</webMaster>
    <copyright>Copyright 2013, Reportlinker</copyright>
    <generator>Zend_Feed</generator>
    <language>en-us</language>
    <docs>http://blogs.law.harvard.edu/tech/rss</docs>
    <item>
      <title><![CDATA[Company Report: Controlled Release Delivery and Drug Delivery in France and The United States for Year 2013]]></title>
      <link>http://www.reportlinker.com/d014180572/Company-Report-Controlled-Release-Delivery-and-Drug-Delivery-in-France-and-The-United-States-for-Year-2013.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d014180572/Company-Report-Controlled-Release-Delivery-and-Drug-Delivery-in-France-and-The-United-States-for-Year-2013.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_pdf_small.gif" width="65px" height="80px"> ... Flml) business model is to blend high-value internally developed  products with its leading <strong>drug</strong> <strong>delivery</strong> capabilities.  The company has a proprietary pipeline of niche  specialty pharmaceutical products ...]]></description>
      <pubDate>Mon, 31 Dec 2012 23:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Transcu Group Ltd. - Company Report for Year 2013]]></title>
      <link>http://www.reportlinker.com/d014096862/Transcu-Group-Ltd-Company-Report-for-Year-2013.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d014096862/Transcu-Group-Ltd-Company-Report-for-Year-2013.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_pdf_small.gif" width="65px" height="80px"> ... As an alternative to injections, oral pills and  other methods of <strong>drug</strong> <strong>delivery</strong> such as transmucosal and inhalation.    Its cosmetic business consists of a women S skincare line, electore. Using mineral ...]]></description>
      <pubDate>Mon, 31 Dec 2012 23:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Company Report: Drug Delivery Technology for Year 2012]]></title>
      <link>http://www.reportlinker.com/d014159590/Company-Report-Drug-Delivery-Technology-for-Year-2012.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d014159590/Company-Report-Drug-Delivery-Technology-for-Year-2012.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_pdf_small.gif" width="65px" height="80px"> ]]></description>
      <pubDate>Fri, 30 Nov 2012 23:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Company Report: Drug Delivery Technology in Australia for Year 2013]]></title>
      <link>http://www.reportlinker.com/d014235563/Company-Report-Drug-Delivery-Technology-in-Australia-for-Year-2013.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d014235563/Company-Report-Drug-Delivery-Technology-in-Australia-for-Year-2013.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_pdf_small.gif" width="65px" height="80px"> ]]></description>
      <pubDate>Thu, 28 Feb 2013 23:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Company Report: Drug Delivery Technology for Year 2013]]></title>
      <link>http://www.reportlinker.com/d014236170/Company-Report-Drug-Delivery-Technology-for-Year-2013.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d014236170/Company-Report-Drug-Delivery-Technology-for-Year-2013.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_pdf_small.gif" width="65px" height="80px"> ]]></description>
      <pubDate>Thu, 28 Feb 2013 23:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Flamel Technologies S.A. - Company Report for Year 2013]]></title>
      <link>http://www.reportlinker.com/d014328876/Flamel-Technologies-S-A-Company-Report-for-Year-2013.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d014328876/Flamel-Technologies-S-A-Company-Report-for-Year-2013.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_pdf_small.gif" width="65px" height="80px"> ... Upon collaborative agreements with pharmaceutical and biotechnology companies to develop, test, obtain regulatory approval for and commercialize products that incorporate our <strong>drug</strong> <strong>delivery</strong> <strong>technologies</strong> ...]]></description>
      <pubDate>Sun, 31 Mar 2013 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Company Report: Drug Delivery in Australia and The United States for Year 2013]]></title>
      <link>http://www.reportlinker.com/d014323412/Company-Report-Drug-Delivery-in-Australia-and-The-United-States-for-Year-2013.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d014323412/Company-Report-Drug-Delivery-in-Australia-and-The-United-States-for-Year-2013.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_pdf_small.gif" width="65px" height="80px"> ... Of imugene platform    linguet   Is a proprietary <strong>drug</strong> <strong>delivery</strong> <strong>technology</strong> that improves the efficacy and  safety of a diverse number of prescription and over the counter medicines. The  platform technology ...]]></description>
      <pubDate>Tue, 30 Apr 2013 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Company Report: Drug Delivery Technology in The United States and Australia for Year 2013]]></title>
      <link>http://www.reportlinker.com/d014298794/Company-Report-Drug-Delivery-Technology-in-The-United-States-and-Australia-for-Year-2013.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d014298794/Company-Report-Drug-Delivery-Technology-in-The-United-States-and-Australia-for-Year-2013.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_pdf_small.gif" width="65px" height="80px"> ]]></description>
      <pubDate>Sun, 31 Mar 2013 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Company Report: Controlled Release Delivery and Drug Delivery in The United States and Canada for Year 2013]]></title>
      <link>http://www.reportlinker.com/d014333848/Company-Report-Controlled-Release-Delivery-and-Drug-Delivery-in-The-United-States-and-Canada-for-Year-2013.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d014333848/Company-Report-Controlled-Release-Delivery-and-Drug-Delivery-in-The-United-States-and-Canada-for-Year-2013.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_pdf_small.gif" width="65px" height="80px"> ... Product cands, and the timing and amount  of any available investment tax credits, the actual or perceived benefits to users of our <strong>drug</strong> <strong>delivery</strong> <strong>technologies</strong> and product  cands as compared ...]]></description>
      <pubDate>Sun, 31 Mar 2013 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[The Future of Inhaled Delivery]]></title>
      <link>http://www.reportlinker.com/d014075831/The-Future-of-Inhaled-Delivery.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d014075831/The-Future-of-Inhaled-Delivery.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_pdf_small.gif" width="65px" height="80px"> ... Forecast the global <strong>nebulizer</strong> market to grow at a cagr  of 5.1 Percent over the period 2011-2015. One of the key factors contributing  to this market growth is the increase in the incidence of lung ...]]></description>
      <pubDate>Mon, 31 Dec 2012 23:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Injectable Drug Delivery to 2018 - Drugs, Devices, Targets, Therapeutics and Forecasts]]></title>
      <link>http://www.reportlinker.com/p01109064/Injectable-Drug-Delivery-to-Drugs-Devices-Targets-Therapeutics-and-Forecasts.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</link>
      <guid>http://www.reportlinker.com/p01109064/Injectable-Drug-Delivery-to-Drugs-Devices-Targets-Therapeutics-and-Forecasts.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</guid>
      <description><![CDATA[<img src="https://d99ngkg9mjpdb.cloudfront.net/public/images/pub/1532.gif"> The past decade has seen a dramatic shift in terms of the types of approved injectable drugs, the diseases they target, and the devices used to deliver them. This shift has fostered change on several levels ...]]></description>
      <pubDate>Thu, 28 Feb 2013 23:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Drug Self-Administration Markets to 2018 - Drug Products, Indications, Markets and Forecasts]]></title>
      <link>http://www.reportlinker.com/p01120778/Drug-Self-Administration-Markets-to-Drug-Products-Indications-Markets-and-Forecasts.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</link>
      <guid>http://www.reportlinker.com/p01120778/Drug-Self-Administration-Markets-to-Drug-Products-Indications-Markets-and-Forecasts.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</guid>
      <description><![CDATA[<img src="https://d99ngkg9mjpdb.cloudfront.net/public/images/pub/1532.gif"> While alternative methods for delivering therapeutics to patients have had some notable successes, most drugs continue to be delivered orally. Because they cannot tolerate the first-pass metabolism of ...]]></description>
      <pubDate>Thu, 28 Feb 2013 23:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Injectable Drug Delivery Market by Formulations [Liposomes, Microspheres, & Nanoparticles], Devices [Disposables & Reusable, Fillable & Prefilled, Pen, Needle Free & Auto Injectors] & Therapeutics [Diabetes & Oncology] - Global Forecasts to 2017]]></title>
      <link>http://www.reportlinker.com/p01157680/Injectable-Drug-Delivery-Market-by-Formulations-Liposomes-Microspheres-Nanoparticles-Devices-Disposables-Reusable-Fillable-Prefilled-Pen-Needle-Free-Auto-Injectors-Therapeutics-Diabetes-Oncology-Global-Forecasts-to.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</link>
      <guid>http://www.reportlinker.com/p01157680/Injectable-Drug-Delivery-Market-by-Formulations-Liposomes-Microspheres-Nanoparticles-Devices-Disposables-Reusable-Fillable-Prefilled-Pen-Needle-Free-Auto-Injectors-Therapeutics-Diabetes-Oncology-Global-Forecasts-to.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</guid>
      <description><![CDATA[<img src="https://d99ngkg9mjpdb.cloudfront.net/public/images/pub/1329.gif"> The global injectable drug delivery technologies market was valued at $22.5 billion in 2012, and is expected to reach $43.3 billion by 2017 at a CAGR of 14.0% from 2012 to 2017. Injectable drug delivery ...]]></description>
      <pubDate>Tue, 02 Apr 2013 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Drug Delivery Technologies Market (Metered Dose Inhalers, Needle-Free Injectors, Auto-Injectors, Nasal Sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release, Ocular Implants) - Global Forecasts To 2017]]></title>
      <link>http://www.reportlinker.com/p01165168/Drug-Delivery-Technologies-Market-Metered-Dose-Inhalers-Needle-Free-Injectors-Auto-Injectors-Nasal-Sprays-Transdermal-Patches-Nebulizers-Infusion-Pumps-Drug-Eluting-Stents-Sustained-Release-Ocular-Implants-Global-Forecasts-To.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</link>
      <guid>http://www.reportlinker.com/p01165168/Drug-Delivery-Technologies-Market-Metered-Dose-Inhalers-Needle-Free-Injectors-Auto-Injectors-Nasal-Sprays-Transdermal-Patches-Nebulizers-Infusion-Pumps-Drug-Eluting-Stents-Sustained-Release-Ocular-Implants-Global-Forecasts-To.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</guid>
      <description><![CDATA[<img src="https://d99ngkg9mjpdb.cloudfront.net/public/images/pub/1329.gif"> The drug delivery technology market is segmented on the basis of route of administration into nine categories - oral, pulmonary, transdermal, injectable, ocular, nasal, topical, implantable, and transmucosal ...]]></description>
      <pubDate>Tue, 23 Apr 2013 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[North America Injectable Drug Delivery Market - by Formulations [Liposomes, Microspheres, & Nanoparticles], Devices [Disposables & Reusable, Fillable & Prefilled, Pen, Needle Free & Auto Injectors] & Therapeutics [Diabetes & Oncology] - Forecasts to 2017]]></title>
      <link>http://www.reportlinker.com/p01158258/North-America-Injectable-Drug-Delivery-Market-by-Formulations-Liposomes-Microspheres-Nanoparticles-Devices-Disposables-Reusable-Fillable-Prefilled-Pen-Needle-Free-Auto-Injectors-Therapeutics-Diabetes-Oncology-Forecasts-to.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</link>
      <guid>http://www.reportlinker.com/p01158258/North-America-Injectable-Drug-Delivery-Market-by-Formulations-Liposomes-Microspheres-Nanoparticles-Devices-Disposables-Reusable-Fillable-Prefilled-Pen-Needle-Free-Auto-Injectors-Therapeutics-Diabetes-Oncology-Forecasts-to.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</guid>
      <description><![CDATA[<img src="https://d99ngkg9mjpdb.cloudfront.net/public/images/pub/1329.gif"> The North American injectable drug delivery technologies market was valued at $9.3 billion in 2012; it is expected to reach $16.6 billion by 2017 at a CAGR of 12.3% from 2012 to 2017. Injectable drug delivery ...]]></description>
      <pubDate>Sun, 07 Apr 2013 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Implantable Drug Delivery Devices (Contraceptives, Drug Infusion Pumps, Intraocular Implants, Drug Eluting, Bio-Absorbable Stents, Biodegradable) Market - Global Industry Analysis, Size, Share, Trends And Forecast, 2012 - 2018]]></title>
      <link>http://www.reportlinker.com/p01118374/Implantable-Drug-Delivery-Devices-Contraceptives-Drug-Infusion-Pumps-Intraocular-Implants-Drug-Eluting-Bio-Absorbable-Stents-Biodegradable-Market-Global-Industry-Analysis-Size-Share-Trends-And-Forecast.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</link>
      <guid>http://www.reportlinker.com/p01118374/Implantable-Drug-Delivery-Devices-Contraceptives-Drug-Infusion-Pumps-Intraocular-Implants-Drug-Eluting-Bio-Absorbable-Stents-Biodegradable-Market-Global-Industry-Analysis-Size-Share-Trends-And-Forecast.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</guid>
      <description><![CDATA[<img src="https://d99ngkg9mjpdb.cloudfront.net/public/images/pub/1601.gif"> The global implantable drug delivery devices hold a competitive edge over other drugs and devices owing to the fact that they are implanted at targeted sites and so deliver unaltered amounts of drugs to ...]]></description>
      <pubDate>Sun, 03 Mar 2013 23:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Prefilled Syringes to 2018 - Devices, Drugs, Markets, Players and Prospects]]></title>
      <link>http://www.reportlinker.com/p01109062/Prefilled-Syringes-to-Devices-Drugs-Markets-Players-and-Prospects.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</link>
      <guid>http://www.reportlinker.com/p01109062/Prefilled-Syringes-to-Devices-Drugs-Markets-Players-and-Prospects.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</guid>
      <description><![CDATA[<img src="https://d99ngkg9mjpdb.cloudfront.net/public/images/pub/1532.gif"> The administration of therapeutic drugs via injection is an indispensable delivery method for numerous drugs critical to patient health and well-being. Now this segment is evolving in response to changing ...]]></description>
      <pubDate>Thu, 28 Feb 2013 23:00:00 +0000</pubDate>
    </item>
  </channel>
</rss>
